Microbot Medical Inc (MBOT) - Total Assets
Based on the latest financial reports, Microbot Medical Inc (MBOT) holds total assets worth $78.07 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Microbot Medical Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Microbot Medical Inc - Total Assets Trend (1991–2025)
This chart illustrates how Microbot Medical Inc's total assets have evolved over time, based on quarterly financial data. Check Microbot Medical Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Microbot Medical Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Microbot Medical Inc's total assets of $78.07 Million consist of 97.9% current assets and 2.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 4.8% |
| Accounts Receivable | $241.00K | 0.3% |
| Inventory | $584.00K | 0.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1991–2025)
This chart illustrates how Microbot Medical Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see MBOT stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Microbot Medical Inc's current assets represent 97.9% of total assets in 2025, an increase from 87.3% in 1991.
- Cash Position: Cash and equivalents constituted 4.8% of total assets in 2025, down from 85.0% in 1991.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 1991.
- Asset Diversification: The largest asset category is inventory at 0.7% of total assets.
Microbot Medical Inc Competitors by Total Assets
Key competitors of Microbot Medical Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
AVE Science & Technology Co Ltd
SHG:688067
|
China | CN¥611.46 Million |
|
MEDIMI AB AK
F:79T
|
Germany | €1.70 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.33 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$135.84 Million |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
|
Trajan Group Holdings Ltd
AU:TRJ
|
Australia | AU$192.32 Million |
Microbot Medical Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 22.59 | 16.19 | 17.41 |
| Quick Ratio | 21.93 | 16.19 | 17.41 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $73.14 Million | $28.76 Million | $19.76 Million |
Microbot Medical Inc - Advanced Valuation Insights
This section examines the relationship between Microbot Medical Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.65 |
| Latest Market Cap to Assets Ratio | 1.48 |
| Asset Growth Rate (YoY) | 1252.1% |
| Total Assets | $81.54 Million |
| Market Capitalization | $120.89 Million USD |
Valuation Analysis
Above Book Valuation: The market values Microbot Medical Inc's assets above their book value (1.48x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Microbot Medical Inc's assets grew by 1252.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Microbot Medical Inc (1991–2025)
The table below shows the annual total assets of Microbot Medical Inc from 1991 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $81.54 Million | +1252.08% |
| 2024-12-31 | $6.03 Million | -27.57% |
| 2023-12-31 | $8.33 Million | -12.69% |
| 2022-12-31 | $9.54 Million | -43.12% |
| 2021-12-31 | $16.77 Million | -36.20% |
| 2020-12-31 | $26.28 Million | -29.22% |
| 2019-12-31 | $37.13 Million | +509.62% |
| 2018-12-31 | $6.09 Million | -44.74% |
| 2017-12-31 | $11.02 Million | +227.20% |
| 2016-12-31 | $3.37 Million | -84.13% |
| 2015-12-31 | $21.22 Million | -34.56% |
| 2014-12-31 | $32.43 Million | -21.97% |
| 2013-12-31 | $41.56 Million | +37.74% |
| 2012-12-31 | $30.17 Million | +19.70% |
| 2011-12-31 | $25.21 Million | -17.63% |
| 2010-12-31 | $30.60 Million | -40.22% |
| 2009-12-31 | $51.19 Million | +24.16% |
| 2008-12-31 | $41.23 Million | -14.61% |
| 2007-12-31 | $48.28 Million | -27.78% |
| 2006-12-31 | $66.86 Million | +49.11% |
| 2005-12-31 | $44.84 Million | -5.86% |
| 2004-12-31 | $47.63 Million | +140.71% |
| 2003-12-31 | $19.79 Million | +74.66% |
| 2002-12-31 | $11.33 Million | -45.54% |
| 2001-12-31 | $20.80 Million | -30.18% |
| 2000-12-31 | $29.79 Million | +88.80% |
| 1999-12-31 | $15.78 Million | -52.03% |
| 1998-12-31 | $32.90 Million | -25.73% |
| 1997-12-31 | $44.30 Million | -24.14% |
| 1996-12-31 | $58.40 Million | +2.82% |
| 1995-12-31 | $56.80 Million | +76.40% |
| 1994-12-31 | $32.20 Million | -21.46% |
| 1993-12-31 | $41.00 Million | +16.48% |
| 1992-12-31 | $35.20 Million | +103.47% |
| 1991-12-31 | $17.30 Million | -- |
About Microbot Medical Inc
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, periph… Read more